VYYRF 0.07 Voyageur Pharmaceuticals Ltd.
| Range: | 5.0E-4-0.078 | Vol Avg: | 1337 | Last Div: | 0 | Changes: | 0.01 |
| Beta: | 0.32 | Cap: | 0.01B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Thu Oct 19 2017 | Empoloyees: | |||
| CUSIP: | CIK: | ISIN: | CA92918C1014 | Country: | CA | ||
| CEO: | Mr. Brent Willis Bsc.Eng | Website: | https://voyageurpharmaceuticals.ca | ||||
Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. The company intends to develop barium and iodine radiocontrast products and bromine based pharmaceutical products. It holds 100% interest in three barium sulfate deposits, including two properties suitable in grade for the pharmaceutical barite marketplace located in British Columbia, Canada; and interests in a high-grade iodine, lithium, and bromine brine project in Utah, the United States. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow